These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosis.
    Author: Jouannaud V, Cadranel JF, Dumouchel P, Cazier A, Capron D, Rochette J, Barbare JC.
    Journal: Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1310-3. PubMed ID: 19478679.
    Abstract:
    Increased ferritin levels are common in the course of chronic hepatitis C, regardless of antiviral therapy. Usually, this increase in ferritin levels has minimal clinical and biological impact, and drops after therapy discontinuation. We report here on a dramatic increase in ferritin levels in a cirrhotic patient with hepatitis C treated by ribavirin monotherapy and oral iron sulphate, and discuss the possible mechanisms of this deleterious effect.
    [Abstract] [Full Text] [Related] [New Search]